Effect of ocrelizumab on leptomeningeal inflammation and humoral response to Epstein-Barr virus in multiple sclerosis. A pilot study

Robert Zivadinov, Dejan Jakimovski, Murali Ramanathan, Ralph H. B. Benedict, Niels Bergsland, Michael G. Dwyer, Bianca Weinstock‐Guttman